As previously reported, the Ministry of Health and Medical
Industry of Turkmenistan registered the “Sputnik Light” vaccine
and issued a corresponding certificate for its use.
Thus, Turkmenistan became one of the first countries to
approve the use of Russian vaccines “Sputnik V”,
“EpiVacCorona” and “Sputnik Light” on its territory.
Vaccination with these preparations will allow the
population to develop immunity more quickly. According to the
Russian Direct Investment Fund (RDIF), “Sputnik Light’s”
effectiveness rate of about 80% exceeds that of other vaccines
requiring the use of two components.
To date, Turkmenistan has separately purchased over
600,000 doses of the two-component vaccine “Sputnik V”. Also,
step-by-step work on further procurement of this line of
preparations is continuing.
As is known, the Ministry of Health and Medical Industry of
Turkmenistan actively cooperates with the leading centers of
virology of the Russian Federation. The registration of “Sputnik
Light” in Turkmenistan is the result of close partnership of the
two countries in the fight against the spread of infectious diseases.